Percheron Therapeutics (ASX:PER) Debt-to-Equity : 0.00 (As of Dec. 2023)

Percheron Therapeutics Debt-to-Equity Chart

Percheron Therapeutics Annual Data
	Trend	Jun14	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23
Debt-to-Equity		Get a 7-Day Free Trial					-	0.03	0.05	0.01	0.01

Percheron Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	-

Competitive Comparison of Percheron Therapeutics's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Percheron Therapeutics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Percheron Therapeutics's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Percheron Therapeutics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Percheron Therapeutics's Debt-to-Equity falls into.

Percheron Therapeutics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Percheron Therapeutics's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Percheron Therapeutics's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Percheron Therapeutics  (ASX:PER) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Percheron Therapeutics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Percheron Therapeutics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Percheron Therapeutics (ASX:PER) Business Description